The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Previous work has shown an association between the K variant of the butyrylcholinesterase (BCHE) gene and Alzheimer's disease (AD) in patients carrying the epsilon4 allele of ApoE. We attempted to replicate this finding in 181 UK white AD cases and 71 controls. No difference was found in BCHE-K...

Detaylı Bibliyografya
Asıl Yazarlar:	Kehoe, P, Williams, H, Holmans, P, Wilcock, G, Cairns, N, Neal, J, Owen, M
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	1998

Benzer Materyaller

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
Yazar:: Roger M. Lane, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
Yazar:: Lehmann, D, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Presenilin-1 polymorphism and Alzheimer's disease [6]
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
Yazar:: Holmes, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

ApoE epsilon 2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes
Yazar:: Horton, V, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
Yazar:: Blomqvist, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Butyrylcholinesterase K variant is associated with type 2 diabetes in UK Caucasians
Yazar:: Hashim, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients
Yazar:: Pongthanaracht N, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Flavonoids as Inhibitors of Human Butyrylcholinesterase Variants
Yazar:: Maja Katalinić, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
Yazar:: Tasker, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Common variants of ACE contribute to variable age at onset of Alzheimer's disease
Yazar:: Katzov, H, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
Yazar:: Katzov, H, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
Yazar:: Vitor G.L. Dantas, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
Yazar:: Sani Muhammad Uzairu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.
Yazar:: Hashim, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
Yazar:: Culpan, D, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Benzene-1,3-diol derivatives as the inhibitors of butyrylcholinesterase: An emergent target of Alzheimer’s disease
Yazar:: Dongliang Yin, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
Yazar:: Shuang Miao, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could <i>BCHE</i> Genotyping Be Helpful in Alzheimer’s Therapy?
Yazar:: Jacek Jasiecki, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease
Yazar:: Culpan, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
Yazar:: Chalmers, K, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer Brain
Yazar:: Marsel Mesulam, ve diğerleri
Baskı/Yayın Bilgisi: (2002-02-01)

Haplotypes extending across ACE are associated with Alzheimer's disease.
Yazar:: Kehoe, P, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Yazar:: Chuanyu Yu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
Yazar:: Ana Matošević, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Investigation of Association between Susceptibility to Leprosy and SNPs inside and near the BCHE Gene of Butyrylcholinesterase
Yazar:: Henrique J. P. Gomes, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

The ACE gene and Alzheimer's disease susceptibility.
Yazar:: Narain, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Biophenols of mints: Antioxidant, acetylcholinesterase, butyrylcholinesterase and histone deacetylase inhibition activities targeting Alzheimer’s disease treatment
Yazar:: Doaa M. Hanafy, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease
Yazar:: Mohamed Elsawalhy, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka.
Yazar:: Leo Pezzementi, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Treating Alzheimer's disease.
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
Yazar:: Leo Pezzementi, ve diğerleri
Baskı/Yayın Bilgisi: (2011-02-01)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
Yazar:: Miners, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
Yazar:: Culpan, D, ve diğerleri
Baskı/Yayın Bilgisi: (2007)